Vimarsana
Biggest News Aggregation in the World

David Elsberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Elsberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Elsberg Today - Breaking & Trending Today

Selendy Gay Spin-Off Firm Opens Its Doors, With More Partners From The Elite Boutique In Tow - Vimarsana News

Selendy Gay Spin-Off Firm Opens Its Doors, With More Partners From The Elite Boutique In Tow

Elsberg Baker & Maruri is looking to hire 14 new associates in the coming months.

Selendy Gay Elsberg Announces Name Change As Founding Partner Leaves To Start His Own Firm - Vimarsana News

Selendy Gay Elsberg Announces Name Change As Founding Partner Leaves To Start His Own Firm

David Elsberg is leaving Selendy Gay and reuniting with his former Quinn Emanuel colleagues to form another litigation and trial firm.

Pro Bono Innovators 2023 Honoree Selendy Gay Elsberg - Vimarsana News

Pro Bono Innovators 2023 Honoree Selendy Gay Elsberg

In our 2023 issue of Pro Bono Innovators, Bloomberg Law honors Selendy Gay Elsberg for securing favorable terms for Sandy Hook school shooting victims’ families in the Remington debtors’ bankruptcy plan, thereby facilitating a $73 million settlement for the families in 2022. We also note the firm’s work helping launch an international nonprofit evacuating and resettling at-risk girls and community members from Afghanistan following the Taliban’s takeover.

Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug - Vimarsana News

Bristol Myers must face $6.4 billion lawsuit over delayed cancer drug

By Jonathan Stempel NEW YORK (Reuters) - A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying...

Source: whbl.com
Bristol Myers must face $6.4 bn lawsuit over delayed cancer drug: US judge - Vimarsana News

Bristol Myers must face $6.4 bn lawsuit over delayed cancer drug: US judge

New York: A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying its Breyanzi cancer drug to av...